These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis. Guedes LR; Cançado GGL; Santos BC; Jacomassi LDS; Nardelli MJ; Osório FMF; Faria LC; Couto CA Ann Hepatol; 2024; 29(4):101497. PubMed ID: 38460715 [TBL] [Abstract][Full Text] [Related]
23. Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial. Stoelinga AEC; Tushuizen ME; van den Hout WB; Girondo MDMR; de Vries ES; Levens AD; Moes DAR; Gevers TJG; van der Meer S; Brouwer HT; de Jonge HJM; de Boer YS; Beuers UHW; van der Meer AJ; van den Berg AP; Guichelaar MMJ; Drenth JPH; van Hoek B; Trials; 2024 Jan; 25(1):61. PubMed ID: 38233878 [TBL] [Abstract][Full Text] [Related]
24. Development of autoimmune hepatitis in a psoriasis patient without immunosuppressive therapy. Jo W; Suh YS; Lee SI; Cheon YH; Hong J; Lee SS; Kim JE; Ko GH; Kim HO Clin Mol Hepatol; 2017 Jun; 23(2):184-187. PubMed ID: 28479589 [TBL] [Abstract][Full Text] [Related]
25. Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study. Plagiannakos CG; Hirschfield GM; Lytvyak E; Roberts SB; Ismail M; Gulamhusein AF; Selzner N; Qumosani KM; Worobetz L; Hercun J; Vincent C; Flemming JA; Swain MG; Cheung A; Chen T; Grbic D; Peltekain K; Mason AL; Montano-Loza AJ; Hansen BE; J Hepatol; 2024 Aug; 81(2):227-237. PubMed ID: 38527524 [TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy. Than NN; Wiegard C; Weiler-Normann C; Füssel K; Mann J; Hodson J; Hirschfield GM; Lohse AW; Adams DH; Schramm C; Oo YH Scand J Gastroenterol; 2016 Mar; 51(3):329-36. PubMed ID: 26458216 [TBL] [Abstract][Full Text] [Related]
28. Characteristics of autoimmune hepatitis in Taiwan: the 11 years' experiences of a medical center. Huang HC; Huang YS; Wu JC; Tsay SH; Huo TI; Wang YJ; Lo JC; Chen CY; Li CP; Chang FY; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 2002 Dec; 65(12):563-9. PubMed ID: 12636201 [TBL] [Abstract][Full Text] [Related]
30. Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study. Ngu JH; Gearry RB; Frampton CM; Stedman CA Hepatology; 2013 Jun; 57(6):2399-406. PubMed ID: 23359353 [TBL] [Abstract][Full Text] [Related]
31. Incidence and Characteristics of Autoimmune Hepatitis. Jiménez-Rivera C; Ling SC; Ahmed N; Yap J; Aglipay M; Barrowman N; Graitson S; Critch J; Rashid M; Ng VL; Roberts EA; Brill H; Dowhaniuk JK; Bruce G; Bax K; Deneau M; Guttman OR; Schreiber RA; Martin S; Alvarez F Pediatrics; 2015 Nov; 136(5):e1237-48. PubMed ID: 26482664 [TBL] [Abstract][Full Text] [Related]
32. Long-term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country. Choi J; Choi GH; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS; Kim KM Liver Int; 2019 May; 39(5):985-994. PubMed ID: 30821090 [TBL] [Abstract][Full Text] [Related]
33. Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience. Karakoyun M; Ecevit CO; Kilicoglu E; Aydogdu S; Yagci RV; Ozgenc F Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):927-30. PubMed ID: 27254777 [TBL] [Abstract][Full Text] [Related]
34. Wilson's disease with superimposed autoimmune features: report of two cases and review. Milkiewicz P; Saksena S; Hubscher SG; Elias E J Gastroenterol Hepatol; 2000 May; 15(5):570-4. PubMed ID: 10847448 [TBL] [Abstract][Full Text] [Related]
35. Autoimmune hepatitis in Iranian children. Rafeey M; Kianrad M; Hasani A Indian J Gastroenterol; 2007; 26(1):11-3. PubMed ID: 17401227 [TBL] [Abstract][Full Text] [Related]
36. Autoimmune hepatitis in Egyptian children: A single center experience. Mogahed E; El-Karaksy H; Zaki H; Abdullatif H Int J Immunopathol Pharmacol; 2022; 36():20587384211073265. PubMed ID: 35231187 [TBL] [Abstract][Full Text] [Related]
37. EVALUATION OF PATIENTS WITH AUTOIMMUNE HEPATITIS IN A SPECIALIZED OUTPATIENT CLINIC IN SOUTHERN BRAZIL. Fedrizzi RS; Coral GP; Mattos AA; Mattos ÂZ; Tovo CV Arq Gastroenterol; 2020; 57(4):361-365. PubMed ID: 33237214 [TBL] [Abstract][Full Text] [Related]
38. Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes. Aljumah AA; Al-Ashgar H; Fallatah H; Albenmousa A Ann Hepatol; 2019; 18(3):439-444. PubMed ID: 31040094 [TBL] [Abstract][Full Text] [Related]